Covid-19 roundup: Oxford Biomedica and AstraZeneca extend vaccine deal; FDA wants boosters for newer variants
An Oxford University spinout and one of the major players in the pharma industry are extending their collaboration on its Covid shot.
Oxford Biomedica and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
